ONTOLOGY,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
BP,GO:0002399,MHC class II protein complex assembly,2月13日,12/18112,3.13E-05,0.006837883,0.003733284,RT1-Db1/RT1-Bb,2
BP,GO:0002503,peptide antigen assembly with MHC class II protein complex,2月13日,12/18112,3.13E-05,0.006837883,0.003733284,RT1-Db1/RT1-Bb,2
BP,GO:0002396,MHC protein complex assembly,2月13日,16/18112,5.67E-05,0.006837883,0.003733284,RT1-Db1/RT1-Bb,2
BP,GO:0002501,peptide antigen assembly with MHC protein complex,2月13日,16/18112,5.67E-05,0.006837883,0.003733284,RT1-Db1/RT1-Bb,2
BP,GO:0050852,T cell receptor signaling pathway,3月13日,129/18112,9.58E-05,0.007551012,0.004122632,RT1-Db1/RT1-Bb/Cyld,3
BP,GO:0019886,antigen processing and presentation of exogenous peptide antigen via MHC class II,2月13日,21/18112,9.91E-05,0.007551012,0.004122632,RT1-Db1/RT1-Bb,2
BP,GO:0050868,negative regulation of T cell activation,3月13日,135/18112,0.000109662,0.007551012,0.004122632,RT1-Db1/RT1-Bb/Cyld,3
BP,GO:1903038,negative regulation of leukocyte cell-cell adhesion,3月13日,146/18112,0.000138314,0.007570008,0.004133003,RT1-Db1/RT1-Bb/Cyld,3
BP,GO:0002495,antigen processing and presentation of peptide antigen via MHC class II,2月13日,25/18112,0.000141349,0.007570008,0.004133003,RT1-Db1/RT1-Bb,2
BP,GO:0002504,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,2月13日,27/18112,0.000165244,0.007964766,0.004348529,RT1-Db1/RT1-Bb,2
BP,GO:0050851,antigen receptor-mediated signaling pathway,3月13日,170/18112,0.00021682,0.009193934,0.005019619,RT1-Db1/RT1-Bb/Cyld,3
BP,GO:0051250,negative regulation of lymphocyte activation,3月13日,176/18112,0.000240144,0.009193934,0.005019619,RT1-Db1/RT1-Bb/Cyld,3
BP,GO:0002478,antigen processing and presentation of exogenous peptide antigen,2月13日,33/18112,0.000247969,0.009193934,0.005019619,RT1-Db1/RT1-Bb,2
BP,GO:0022408,negative regulation of cell-cell adhesion,3月13日,206/18112,0.00038125,0.011568192,0.006315894,RT1-Db1/RT1-Bb/Cyld,3
BP,GO:0019884,antigen processing and presentation of exogenous antigen,2月13日,41/18112,0.000383858,0.011568192,0.006315894,RT1-Db1/RT1-Bb,2
BP,GO:0002695,negative regulation of leukocyte activation,3月13日,208/18112,0.000392192,0.011568192,0.006315894,RT1-Db1/RT1-Bb/Cyld,3
BP,GO:0050870,positive regulation of T cell activation,3月13日,216/18112,0.000437985,0.011568192,0.006315894,RT1-Db1/RT1-Bb/Cyld,3
BP,GO:0002429,immune response-activating cell surface receptor signaling pathway,3月13日,218/18112,0.000449948,0.011568192,0.006315894,RT1-Db1/RT1-Bb/Cyld,3
BP,GO:0002757,immune response-activating signal transduction,3月13日,219/18112,0.000456008,0.011568192,0.006315894,RT1-Db1/RT1-Bb/Cyld,3
BP,GO:0042088,T-helper 1 type immune response,2月13日,47/18112,0.00050481,0.012165916,0.006642234,RT1-Db1/RT1-Bb,2
BP,GO:0050866,negative regulation of cell activation,3月13日,231/18112,0.000532869,0.012230613,0.006677557,RT1-Db1/RT1-Bb/Cyld,3
BP,GO:0002768,immune response-regulating cell surface receptor signaling pathway,3月13日,237/18112,0.000574235,0.012580976,0.006868845,RT1-Db1/RT1-Bb/Cyld,3
BP,GO:1903039,positive regulation of leukocyte cell-cell adhesion,3月13日,241/18112,0.000602928,0.012635279,0.006898492,RT1-Db1/RT1-Bb/Cyld,3
BP,GO:0048002,antigen processing and presentation of peptide antigen,2月13日,66/18112,0.000994006,0.019962957,0.01089919,RT1-Db1/RT1-Bb,2
BP,GO:0022409,positive regulation of cell-cell adhesion,3月13日,292/18112,0.001052203,0.020089495,0.010968276,RT1-Db1/RT1-Bb/Cyld,3
BP,GO:0002253,activation of immune response,3月13日,298/18112,0.00111585,0.020089495,0.010968276,RT1-Db1/RT1-Bb/Cyld,3
BP,GO:0051251,positive regulation of lymphocyte activation,3月13日,302/18112,0.001159613,0.020089495,0.010968276,RT1-Db1/RT1-Bb/Cyld,3
BP,GO:0051384,response to glucocorticoid,3月13日,304/18112,0.001181898,0.020089495,0.010968276,RT1-Db1/RT1-Bb/S100b,3
BP,GO:0002381,immunoglobulin production involved in immunoglobulin-mediated immune response,2月13日,73/18112,0.001214386,0.020089495,0.010968276,RT1-Db1/RT1-Bb,2
BP,GO:0007162,negative regulation of cell adhesion,3月13日,310/18112,0.001250384,0.020089495,0.010968276,RT1-Db1/RT1-Bb/Cyld,3
BP,GO:0046635,positive regulation of alpha-beta T cell activation,2月13日,76/18112,0.001315373,0.020451925,0.011166152,RT1-Db1/RT1-Bb,2
BP,GO:0042130,negative regulation of T cell proliferation,2月13日,79/18112,0.001420262,0.021392692,0.011679784,RT1-Db1/RT1-Bb,2
BP,GO:0031960,response to corticosteroid,3月13日,332/18112,0.001522911,0.022243735,0.012144428,RT1-Db1/RT1-Bb/S100b,3
BP,GO:1903037,regulation of leukocyte cell-cell adhesion,3月13日,336/18112,0.001576165,0.022344462,0.012199422,RT1-Db1/RT1-Bb/Cyld,3
BP,GO:0050863,regulation of T cell activation,3月13日,343/18112,0.001672168,0.023028139,0.01257269,RT1-Db1/RT1-Bb/Cyld,3
BP,GO:0006637,acyl-CoA metabolic process,2月13日,89/18112,0.001797884,0.02342109,0.01278723,Dip2a/Mcee,2
BP,GO:0035383,thioester metabolic process,2月13日,89/18112,0.001797884,0.02342109,0.01278723,Dip2a/Mcee,2
BP,GO:0050727,regulation of inflammatory response,3月13日,360/18112,0.001920481,0.024359791,0.013299733,RT1-Db1/Cyld/Cdk19,3
BP,GO:0002696,positive regulation of leukocyte activation,3月13日,365/18112,0.001997682,0.024689304,0.013479638,RT1-Db1/RT1-Bb/Cyld,3
BP,GO:0050672,negative regulation of lymphocyte proliferation,2月13日,96/18112,0.002087631,0.024953052,0.013623636,RT1-Db1/RT1-Bb,2
BP,GO:0032945,negative regulation of mononuclear cell proliferation,2月13日,97/18112,0.002130719,0.024953052,0.013623636,RT1-Db1/RT1-Bb,2
BP,GO:0007159,leukocyte cell-cell adhesion,3月13日,376/18112,0.002174332,0.024953052,0.013623636,RT1-Db1/RT1-Bb/Cyld,3
BP,GO:0045582,positive regulation of T cell differentiation,2月13日,101/18112,0.002307287,0.025197683,0.013757197,RT1-Db1/Cyld,2
BP,GO:0050867,positive regulation of cell activation,3月13日,385/18112,0.002325933,0.025197683,0.013757197,RT1-Db1/RT1-Bb/Cyld,3
BP,GO:0070664,negative regulation of leukocyte proliferation,2月13日,102/18112,0.002352481,0.025197683,0.013757197,RT1-Db1/RT1-Bb,2
BP,GO:0002764,immune response-regulating signaling pathway,3月13日,392/18112,0.002448314,0.025654069,0.014006371,RT1-Db1/RT1-Bb/Cyld,3
BP,GO:0033865,nucleoside bisphosphate metabolic process,2月13日,110/18112,0.002729091,0.026308434,0.014363635,Dip2a/Mcee,2
BP,GO:0033875,ribonucleoside bisphosphate metabolic process,2月13日,110/18112,0.002729091,0.026308434,0.014363635,Dip2a/Mcee,2
BP,GO:0034032,purine nucleoside bisphosphate metabolic process,2月13日,110/18112,0.002729091,0.026308434,0.014363635,Dip2a/Mcee,2
BP,GO:0071548,response to dexamethasone,2月13日,110/18112,0.002729091,0.026308434,0.014363635,RT1-Db1/RT1-Bb,2
BP,GO:0019882,antigen processing and presentation,2月13日,114/18112,0.002927381,0.027082045,0.014786004,RT1-Db1/RT1-Bb,2
BP,GO:0046634,regulation of alpha-beta T cell activation,2月13日,114/18112,0.002927381,0.027082045,0.014786004,RT1-Db1/RT1-Bb,2
BP,GO:0030098,lymphocyte differentiation,3月13日,420/18112,0.002977901,0.027082045,0.014786004,RT1-Db1/RT1-Bb/Cyld,3
BP,GO:0045621,positive regulation of lymphocyte differentiation,2月13日,117/18112,0.00308044,0.027495777,0.015011889,RT1-Db1/Cyld,2
BP,GO:0002683,negative regulation of immune system process,3月13日,441/18112,0.003418405,0.029957654,0.016356002,RT1-Db1/RT1-Bb/Cyld,3
BP,GO:0002377,immunoglobulin production,2月13日,130/18112,0.003786326,0.032589449,0.017792886,RT1-Db1/RT1-Bb,2
BP,GO:0022407,regulation of cell-cell adhesion,3月13日,463/18112,0.003921085,0.033157241,0.018102884,RT1-Db1/RT1-Bb/Cyld,3
BP,GO:1903131,mononuclear cell differentiation,3月13日,472/18112,0.004139161,0.034397858,0.018780224,RT1-Db1/RT1-Bb/Cyld,3
BP,GO:0002824,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,2月13日,138/18112,0.004254801,0.034487339,0.018829078,RT1-Db1/RT1-Bb,2
BP,GO:0045785,positive regulation of cell adhesion,3月13日,481/18112,0.00436458,0.034487339,0.018829078,RT1-Db1/RT1-Bb/Cyld,3
BP,GO:0051249,regulation of lymphocyte activation,3月13日,481/18112,0.00436458,0.034487339,0.018829078,RT1-Db1/RT1-Bb/Cyld,3
BP,GO:0002821,positive regulation of adaptive immune response,2月13日,142/18112,0.004498673,0.034973557,0.019094539,RT1-Db1/RT1-Bb,2
BP,GO:0030183,B cell differentiation,2月13日,152/18112,0.00513619,0.039295933,0.021454429,RT1-Bb/Cyld,2
BP,GO:0016064,immunoglobulin mediated immune response,2月13日,154/18112,0.005268433,0.039562142,0.021599772,RT1-Db1/RT1-Bb,2
BP,GO:0034341,response to interferon-gamma,2月13日,155/18112,0.005335144,0.039562142,0.021599772,RT1-Db1/RT1-Bb,2
BP,GO:0019724,B cell mediated immunity,2月13日,159/18112,0.005605901,0.040940064,0.022352077,RT1-Db1/RT1-Bb,2
BP,GO:0045580,regulation of T cell differentiation,2月13日,165/18112,0.006023727,0.043334875,0.023659574,RT1-Db1/Cyld,2
BP,GO:0046631,alpha-beta T cell activation,2月13日,180/18112,0.007129009,0.047411985,0.025885557,RT1-Db1/RT1-Bb,2
BP,GO:0002424,T cell mediated immune response to tumor cell,1月13日,10/18112,0.007156196,0.047411985,0.025885557,RT1-Db1,1
BP,GO:0002840,regulation of T cell mediated immune response to tumor cell,1月13日,10/18112,0.007156196,0.047411985,0.025885557,RT1-Db1,1
BP,GO:0043379,memory T cell differentiation,1月13日,10/18112,0.007156196,0.047411985,0.025885557,RT1-Db1,1
BP,GO:0071317,cellular response to isoquinoline alkaloid,1月13日,10/18112,0.007156196,0.047411985,0.025885557,RT1-Bb,1
BP,GO:0043123,positive regulation of I-kappaB kinase/NF-kappaB signaling,2月13日,183/18112,0.007360366,0.047411985,0.025885557,RT1-Db1/S100b,2
BP,GO:1902107,positive regulation of leukocyte differentiation,2月13日,185/18112,0.007516494,0.047411985,0.025885557,RT1-Db1/Cyld,2
BP,GO:1903708,positive regulation of hemopoiesis,2月13日,185/18112,0.007516494,0.047411985,0.025885557,RT1-Db1/Cyld,2
BP,GO:0042129,regulation of T cell proliferation,2月13日,189/18112,0.007833271,0.047411985,0.025885557,RT1-Db1/RT1-Bb,2
BP,GO:0002361,"CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation",1月13日,11/18112,0.007869209,0.047411985,0.025885557,RT1-Db1,1
BP,GO:0002579,positive regulation of antigen processing and presentation,1月13日,11/18112,0.007869209,0.047411985,0.025885557,RT1-Bb,1
BP,GO:0045657,positive regulation of monocyte differentiation,1月13日,11/18112,0.007869209,0.047411985,0.025885557,RT1-Db1,1
BP,GO:0090715,immunological memory formation process,1月13日,11/18112,0.007869209,0.047411985,0.025885557,RT1-Db1,1
BP,GO:0031644,regulation of nervous system process,2月13日,197/18112,0.008484796,0.050489771,0.027565938,Grin2d/S100b,2
BP,GO:0045619,regulation of lymphocyte differentiation,2月13日,199/18112,0.008651398,0.050853337,0.027764434,RT1-Db1/Cyld,2
BP,GO:0046598,positive regulation of viral entry into host cell,1月13日,13/18112,0.009293818,0.052921168,0.028893409,RT1-Db1,1
BP,GO:0075294,positive regulation by symbiont of entry into host,1月13日,13/18112,0.009293818,0.052921168,0.028893409,RT1-Db1,1
BP,GO:0002822,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,2月13日,207/18112,0.009332571,0.052921168,0.028893409,RT1-Db1/RT1-Bb,2
BP,GO:0060291,long-term synaptic potentiation,2月13日,210/18112,0.009594067,0.0537714,0.029357611,Grin2d/S100b,2
BP,GO:0090713,immunological memory process,1月13日,14/18112,0.010005415,0.055432297,0.030264412,RT1-Db1,1
BP,GO:0002819,regulation of adaptive immune response,2月13日,220/18112,0.010489357,0.057453071,0.031367696,RT1-Db1/RT1-Bb,2
BP,GO:0050862,positive regulation of T cell receptor signaling pathway,1月13日,15/18112,0.010716539,0.058037885,0.031686987,Cyld,1
BP,GO:0002440,production of molecular mediator of immune response,2月13日,225/18112,0.01095053,0.058646174,0.032019095,RT1-Db1/RT1-Bb,2
BP,GO:0042098,T cell proliferation,2月13日,227/18112,0.011137506,0.058992064,0.032207941,RT1-Db1/RT1-Bb,2
BP,GO:0002468,dendritic cell antigen processing and presentation,1月13日,16/18112,0.011427192,0.059224801,0.032335008,RT1-Db1,1
BP,GO:0051597,response to methylmercury,1月13日,16/18112,0.011427192,0.059224801,0.032335008,S100b,1
BP,GO:0016045,detection of bacterium,1月13日,17/18112,0.012137373,0.062236319,0.033979209,RT1-Db1,1
BP,GO:0043122,regulation of I-kappaB kinase/NF-kappaB signaling,2月13日,245/18112,0.012884014,0.064694537,0.035321324,RT1-Db1/S100b,2
BP,GO:0006959,humoral immune response,2月13日,249/18112,0.013287538,0.064694537,0.035321324,RT1-Db1/RT1-Bb,2
BP,GO:0050670,regulation of lymphocyte proliferation,2月13日,249/18112,0.013287538,0.064694537,0.035321324,RT1-Db1/RT1-Bb,2
BP,GO:0002827,positive regulation of T-helper 1 type immune response,1月13日,19/18112,0.013556324,0.064694537,0.035321324,RT1-Bb,1
BP,GO:0002862,negative regulation of inflammatory response to antigenic stimulus,1月13日,19/18112,0.013556324,0.064694537,0.035321324,RT1-Db1,1
BP,GO:0006085,acetyl-CoA biosynthetic process,1月13日,19/18112,0.013556324,0.064694537,0.035321324,Dip2a,1
BP,GO:0045655,regulation of monocyte differentiation,1月13日,19/18112,0.013556324,0.064694537,0.035321324,RT1-Db1,1
BP,GO:0032944,regulation of mononuclear cell proliferation,2月13日,253/18112,0.013696602,0.064723157,0.035336949,RT1-Db1/RT1-Bb,2
BP,GO:0098543,detection of other organism,1月13日,20/18112,0.014265094,0.066755098,0.03644633,RT1-Db1,1
BP,GO:0002577,regulation of antigen processing and presentation,1月13日,21/18112,0.014973393,0.067450238,0.036825856,RT1-Bb,1
BP,GO:0002836,positive regulation of response to tumor cell,1月13日,21/18112,0.014973393,0.067450238,0.036825856,RT1-Db1,1
BP,GO:0002839,positive regulation of immune response to tumor cell,1月13日,21/18112,0.014973393,0.067450238,0.036825856,RT1-Db1,1
BP,GO:0019985,translesion synthesis,1月13日,21/18112,0.014973393,0.067450238,0.036825856,Sprtn,1
BP,GO:0070663,regulation of leukocyte proliferation,2月13日,271/18112,0.015605131,0.068712267,0.037514887,RT1-Db1/RT1-Bb,2
BP,GO:0043369,"CD4-positive or CD8-positive, alpha-beta T cell lineage commitment",1月13日,22/18112,0.015681223,0.068712267,0.037514887,Cyld,1
BP,GO:2001014,regulation of skeletal muscle cell differentiation,1月13日,22/18112,0.015681223,0.068712267,0.037514887,S100b,1
BP,GO:0007249,I-kappaB kinase/NF-kappaB signaling,2月13日,278/18112,0.016376882,0.070529437,0.038507009,RT1-Db1/S100b,2
BP,GO:0050857,positive regulation of antigen receptor-mediated signaling pathway,1月13日,23/18112,0.016388583,0.070529437,0.038507009,Cyld,1
BP,GO:0031643,positive regulation of myelination,1月13日,24/18112,0.017095474,0.071034641,0.038782835,S100b,1
BP,GO:0045591,positive regulation of regulatory T cell differentiation,1月13日,24/18112,0.017095474,0.071034641,0.038782835,RT1-Db1,1
BP,GO:0060544,regulation of necroptotic process,1月13日,24/18112,0.017095474,0.071034641,0.038782835,Cyld,1
BP,GO:1903902,positive regulation of viral life cycle,1月13日,24/18112,0.017095474,0.071034641,0.038782835,RT1-Db1,1
BP,GO:0042113,B cell activation,2月13日,289/18112,0.017622519,0.072598752,0.039636794,RT1-Bb/Cyld,2
BP,GO:0098581,detection of external biotic stimulus,1月13日,26/18112,0.018507849,0.074522745,0.040687238,RT1-Db1,1
BP,GO:0030217,T cell differentiation,2月13日,297/18112,0.01855338,0.074522745,0.040687238,RT1-Db1/Cyld,2
BP,GO:0050806,positive regulation of synaptic transmission,2月13日,297/18112,0.01855338,0.074522745,0.040687238,Grin2d/S100b,2
BP,GO:0016540,protein autoprocessing,1月13日,27/18112,0.019213334,0.075291274,0.041106833,Sprtn,1
BP,GO:0062098,regulation of programmed necrotic cell death,1月13日,27/18112,0.019213334,0.075291274,0.041106833,Cyld,1
BP,GO:1901223,negative regulation of NIK/NF-kappaB signaling,1月13日,27/18112,0.019213334,0.075291274,0.041106833,Cyld,1
BP,GO:0002837,regulation of immune response to tumor cell,1月13日,28/18112,0.01991835,0.076195594,0.041600564,RT1-Db1,1
BP,GO:0035235,ionotropic glutamate receptor signaling pathway,1月13日,28/18112,0.01991835,0.076195594,0.041600564,Grin2d,1
BP,GO:1990806,ligand-gated ion channel signaling pathway,1月13日,28/18112,0.01991835,0.076195594,0.041600564,Grin2d,1
BP,GO:0002360,T cell lineage commitment,1月13日,29/18112,0.020622899,0.077658104,0.042399052,Cyld,1
BP,GO:0006301,postreplication repair,1月13日,29/18112,0.020622899,0.077658104,0.042399052,Sprtn,1
BP,GO:0002449,lymphocyte mediated immunity,2月13日,317/18112,0.020970798,0.078356004,0.042780085,RT1-Db1/RT1-Bb,2
BP,GO:0006790,sulfur compound metabolic process,2月13日,319/18112,0.021219533,0.078470264,0.042842468,Dip2a/Mcee,2
BP,GO:0002825,regulation of T-helper 1 type immune response,1月13日,30/18112,0.02132698,0.078470264,0.042842468,RT1-Bb,1
BP,GO:1902105,regulation of leukocyte differentiation,2月13日,322/18112,0.021594994,0.07871739,0.042977391,RT1-Db1/Cyld,2
BP,GO:0046651,lymphocyte proliferation,2月13日,323/18112,0.021720774,0.07871739,0.042977391,RT1-Db1/RT1-Bb,2
BP,GO:0043372,"positive regulation of CD4-positive, alpha-beta T cell differentiation",1月13日,31/18112,0.022030594,0.078832111,0.043040026,RT1-Db1,1
BP,GO:0032943,mononuclear cell proliferation,2月13日,327/18112,0.022227015,0.078832111,0.043040026,RT1-Db1/RT1-Bb,2
BP,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,2月13日,330/18112,0.022609962,0.078832111,0.043040026,RT1-Db1/RT1-Bb,2
BP,GO:0002418,immune response to tumor cell,1月13日,32/18112,0.022733741,0.078832111,0.043040026,RT1-Db1,1
BP,GO:0002834,regulation of response to tumor cell,1月13日,32/18112,0.022733741,0.078832111,0.043040026,RT1-Db1,1
BP,GO:0045577,regulation of B cell differentiation,1月13日,32/18112,0.022733741,0.078832111,0.043040026,Cyld,1
BP,GO:0002483,antigen processing and presentation of endogenous peptide antigen,1月13日,33/18112,0.023436422,0.078995492,0.043129227,RT1-Db1,1
BP,GO:0035384,thioester biosynthetic process,1月13日,33/18112,0.023436422,0.078995492,0.043129227,Dip2a,1
BP,GO:0070536,protein K63-linked deubiquitination,1月13日,33/18112,0.023436422,0.078995492,0.043129227,Cyld,1
BP,GO:0071616,acyl-CoA biosynthetic process,1月13日,33/18112,0.023436422,0.078995492,0.043129227,Dip2a,1
BP,GO:0000731,DNA synthesis involved in DNA repair,1月13日,34/18112,0.024138636,0.079724583,0.043527289,Sprtn,1
BP,GO:0048167,regulation of synaptic plasticity,2月13日,347/18112,0.02483227,0.079724583,0.043527289,Grin2d/S100b,2
BP,GO:0001964,startle response,1月13日,35/18112,0.024840384,0.079724583,0.043527289,Grin2d,1
BP,GO:0007020,microtubule nucleation,1月13日,35/18112,0.024840384,0.079724583,0.043527289,Tubgcp4,1
BP,GO:0019883,antigen processing and presentation of endogenous antigen,1月13日,35/18112,0.024840384,0.079724583,0.043527289,RT1-Db1,1
BP,GO:0030224,monocyte differentiation,1月13日,35/18112,0.024840384,0.079724583,0.043527289,RT1-Db1,1
BP,GO:0000413,protein peptidyl-prolyl isomerization,1月13日,36/18112,0.025541666,0.079724583,0.043527289,Fkbp11,1
BP,GO:0009595,detection of biotic stimulus,1月13日,36/18112,0.025541666,0.079724583,0.043527289,RT1-Db1,1
BP,GO:0032633,interleukin-4 production,1月13日,36/18112,0.025541666,0.079724583,0.043527289,RT1-Db1,1
BP,GO:0032673,regulation of interleukin-4 production,1月13日,36/18112,0.025541666,0.079724583,0.043527289,RT1-Db1,1
BP,GO:0071108,protein K48-linked deubiquitination,1月13日,36/18112,0.025541666,0.079724583,0.043527289,Cyld,1
BP,GO:0070661,leukocyte proliferation,2月13日,353/18112,0.025637573,0.079724583,0.043527289,RT1-Db1/RT1-Bb,2
BP,GO:0000184,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay",1月13日,37/18112,0.026242482,0.080344245,0.043865607,Smg5,1
BP,GO:0006084,acetyl-CoA metabolic process,1月13日,37/18112,0.026242482,0.080344245,0.043865607,Dip2a,1
BP,GO:0043368,positive T cell selection,1月13日,38/18112,0.026942833,0.080344245,0.043865607,Cyld,1
BP,GO:0045622,regulation of T-helper cell differentiation,1月13日,38/18112,0.026942833,0.080344245,0.043865607,RT1-Db1,1
BP,GO:0070266,necroptotic process,1月13日,38/18112,0.026942833,0.080344245,0.043865607,Cyld,1
BP,GO:2000516,"positive regulation of CD4-positive, alpha-beta T cell activation",1月13日,38/18112,0.026942833,0.080344245,0.043865607,RT1-Db1,1
BP,GO:0009150,purine ribonucleotide metabolic process,2月13日,363/18112,0.027003668,0.080344245,0.043865607,Dip2a/Mcee,2
BP,GO:0046329,negative regulation of JNK cascade,1月13日,39/18112,0.02764272,0.081741048,0.04462822,Cyld,1
BP,GO:0002861,regulation of inflammatory response to antigenic stimulus,1月13日,40/18112,0.028342141,0.082294651,0.044930471,RT1-Db1,1
BP,GO:0045589,regulation of regulatory T cell differentiation,1月13日,40/18112,0.028342141,0.082294651,0.044930471,RT1-Db1,1
BP,GO:2000758,positive regulation of peptidyl-lysine acetylation,1月13日,40/18112,0.028342141,0.082294651,0.044930471,Dip2a,1
BP,GO:0032689,negative regulation of interferon-gamma production,1月13日,41/18112,0.029041098,0.083320293,0.045490442,RT1-Db1,1
BP,GO:2000463,positive regulation of excitatory postsynaptic potential,1月13日,41/18112,0.029041098,0.083320293,0.045490442,Grin2d,1
BP,GO:0009259,ribonucleotide metabolic process,2月13日,382/18112,0.029680263,0.084320488,0.046036519,Dip2a/Mcee,2
BP,GO:0010803,regulation of tumor necrosis factor-mediated signaling pathway,1月13日,42/18112,0.029739591,0.084320488,0.046036519,Cyld,1
BP,GO:0001916,positive regulation of T cell mediated cytotoxicity,1月13日,43/18112,0.03043762,0.084619231,0.046199624,RT1-Db1,1
BP,GO:0010939,regulation of necrotic cell death,1月13日,43/18112,0.03043762,0.084619231,0.046199624,Cyld,1
BP,GO:0051968,"positive regulation of synaptic transmission, glutamatergic",1月13日,43/18112,0.03043762,0.084619231,0.046199624,Grin2d,1
BP,GO:0006163,purine nucleotide metabolic process,2月13日,388/18112,0.030547191,0.084619231,0.046199624,Dip2a/Mcee,2
BP,GO:0019693,ribose phosphate metabolic process,2月13日,392/18112,0.031130846,0.084768855,0.046281314,Dip2a/Mcee,2
BP,GO:0045066,regulatory T cell differentiation,1月13日,44/18112,0.031135186,0.084768855,0.046281314,RT1-Db1,1
BP,GO:0030225,macrophage differentiation,1月13日,45/18112,0.031832288,0.084768855,0.046281314,RT1-Db1,1
BP,GO:0033866,nucleoside bisphosphate biosynthetic process,1月13日,45/18112,0.031832288,0.084768855,0.046281314,Dip2a,1
BP,GO:0034030,ribonucleoside bisphosphate biosynthetic process,1月13日,45/18112,0.031832288,0.084768855,0.046281314,Dip2a,1
BP,GO:0034033,purine nucleoside bisphosphate biosynthetic process,1月13日,45/18112,0.031832288,0.084768855,0.046281314,Dip2a,1
BP,GO:0050856,regulation of T cell receptor signaling pathway,1月13日,45/18112,0.031832288,0.084768855,0.046281314,Cyld,1
BP,GO:1900744,regulation of p38MAPK cascade,1月13日,46/18112,0.032528927,0.086148037,0.047034307,Cyld,1
BP,GO:1903706,regulation of hemopoiesis,2月13日,406/18112,0.033209146,0.087035325,0.047518741,RT1-Db1/Cyld,2
BP,GO:0035774,positive regulation of insulin secretion involved in cellular response to glucose stimulus,1月13日,47/18112,0.033225103,0.087035325,0.047518741,RT1-Db1,1
BP,GO:0046596,regulation of viral entry into host cell,1月13日,48/18112,0.033920817,0.087902334,0.047992102,RT1-Db1,1
BP,GO:0097300,programmed necrotic cell death,1月13日,48/18112,0.033920817,0.087902334,0.047992102,Cyld,1
BP,GO:0002250,adaptive immune response,2月13日,415/18112,0.034573982,0.088444722,0.04828823,RT1-Db1/RT1-Bb,2
BP,GO:0072521,purine-containing compound metabolic process,2月13日,415/18112,0.034573982,0.088444722,0.04828823,Dip2a/Mcee,2
BP,GO:1901654,response to ketone,2月13日,417/18112,0.034880301,0.088444722,0.04828823,RT1-Db1/RT1-Bb,2
BP,GO:0002347,response to tumor cell,1月13日,50/18112,0.035310859,0.088444722,0.04828823,RT1-Db1,1
BP,GO:1901985,positive regulation of protein acetylation,1月13日,50/18112,0.035310859,0.088444722,0.04828823,Dip2a,1
BP,GO:0002443,leukocyte mediated immunity,2月13日,423/18112,0.035805797,0.088444722,0.04828823,RT1-Db1/RT1-Bb,2
BP,GO:0046638,positive regulation of alpha-beta T cell differentiation,1月13日,51/18112,0.036005188,0.088444722,0.04828823,RT1-Db1,1
BP,GO:0001914,regulation of T cell mediated cytotoxicity,1月13日,52/18112,0.036699055,0.088444722,0.04828823,RT1-Db1,1
BP,GO:0032873,negative regulation of stress-activated MAPK cascade,1月13日,52/18112,0.036699055,0.088444722,0.04828823,Cyld,1
BP,GO:0043370,"regulation of CD4-positive, alpha-beta T cell differentiation",1月13日,52/18112,0.036699055,0.088444722,0.04828823,RT1-Db1,1
BP,GO:0045058,T cell selection,1月13日,52/18112,0.036699055,0.088444722,0.04828823,Cyld,1
BP,GO:0045581,negative regulation of T cell differentiation,1月13日,52/18112,0.036699055,0.088444722,0.04828823,Cyld,1
BP,GO:0070303,negative regulation of stress-activated protein kinase signaling cascade,1月13日,52/18112,0.036699055,0.088444722,0.04828823,Cyld,1
BP,GO:0071312,cellular response to alkaloid,1月13日,52/18112,0.036699055,0.088444722,0.04828823,RT1-Bb,1
BP,GO:0018208,peptidyl-proline modification,1月13日,53/18112,0.037392461,0.089667493,0.048955827,Fkbp11,1
BP,GO:0052372,modulation by symbiont of entry into host,1月13日,54/18112,0.038085406,0.090877058,0.049616214,RT1-Db1,1
BP,GO:0007215,glutamate receptor signaling pathway,1月13日,57/18112,0.04016148,0.09489134,0.051807895,Grin2d,1
BP,GO:0038066,p38MAPK cascade,1月13日,57/18112,0.04016148,0.09489134,0.051807895,Cyld,1
BP,GO:0031646,positive regulation of nervous system process,1月13日,58/18112,0.040852585,0.096053395,0.052442343,S100b,1
BP,GO:0043278,response to morphine,1月13日,59/18112,0.041543231,0.096427448,0.052646565,RT1-Bb,1
BP,GO:0009117,nucleotide metabolic process,2月13日,462/18112,0.042055086,0.096427448,0.052646565,Dip2a/Mcee,2
BP,GO:0050832,defense response to fungus,1月13日,60/18112,0.042233417,0.096427448,0.052646565,RT1-Bb,1
BP,GO:0098815,modulation of excitatory postsynaptic potential,1月13日,60/18112,0.042233417,0.096427448,0.052646565,Grin2d,1
BP,GO:2001238,positive regulation of extrinsic apoptotic signaling pathway,1月13日,60/18112,0.042233417,0.096427448,0.052646565,Cyld,1
BP,GO:0014072,response to isoquinoline alkaloid,1月13日,61/18112,0.042923145,0.096427448,0.052646565,RT1-Bb,1
BP,GO:0031641,regulation of myelination,1月13日,61/18112,0.042923145,0.096427448,0.052646565,S100b,1
BP,GO:0045620,negative regulation of lymphocyte differentiation,1月13日,61/18112,0.042923145,0.096427448,0.052646565,Cyld,1
BP,GO:0051930,regulation of sensory perception of pain,1月13日,61/18112,0.042923145,0.096427448,0.052646565,Grin2d,1
BP,GO:0006753,nucleoside phosphate metabolic process,2月13日,470/18112,0.04338572,0.096427448,0.052646565,Dip2a/Mcee,2
BP,GO:0031122,cytoplasmic microtubule organization,1月13日,62/18112,0.043612414,0.096427448,0.052646565,Tubgcp4,1
BP,GO:0048524,positive regulation of viral process,1月13日,62/18112,0.043612414,0.096427448,0.052646565,RT1-Db1,1
BP,GO:0051931,regulation of sensory perception,1月13日,62/18112,0.043612414,0.096427448,0.052646565,Grin2d,1
BP,GO:0050854,regulation of antigen receptor-mediated signaling pathway,1月13日,63/18112,0.044301225,0.097503153,0.053233868,Cyld,1
BP,GO:0032613,interleukin-10 production,1月13日,64/18112,0.044989578,0.097680075,0.053330462,RT1-Db1,1
BP,GO:0032653,regulation of interleukin-10 production,1月13日,64/18112,0.044989578,0.097680075,0.053330462,RT1-Db1,1
BP,GO:0043903,regulation of biological process involved in symbiotic interaction,1月13日,64/18112,0.044989578,0.097680075,0.053330462,RT1-Db1,1
BP,GO:0001913,T cell mediated cytotoxicity,1月13日,65/18112,0.045677474,0.098728889,0.053903084,RT1-Db1,1
BP,GO:0042093,T-helper cell differentiation,1月13日,66/18112,0.046364911,0.099767354,0.054470056,RT1-Db1,1
BP,GO:0070265,necrotic cell death,1月13日,67/18112,0.047051892,0.100795609,0.055031453,Cyld,1
BP,GO:0002294,"CD4-positive, alpha-beta T cell differentiation involved in immune response",1月13日,68/18112,0.047738416,0.100920687,0.055099742,RT1-Db1,1
BP,GO:0061077,chaperone-mediated protein folding,1月13日,68/18112,0.047738416,0.100920687,0.055099742,Fkbp11,1
BP,GO:2000514,"regulation of CD4-positive, alpha-beta T cell activation",1月13日,68/18112,0.047738416,0.100920687,0.055099742,RT1-Db1,1
BP,GO:0002293,alpha-beta T cell differentiation involved in immune response,1月13日,69/18112,0.048424484,0.101924022,0.055647534,RT1-Db1,1
BP,GO:0002287,alpha-beta T cell activation involved in immune response,1月13日,70/18112,0.049110095,0.102472146,0.055946793,RT1-Db1,1
BP,GO:1902017,regulation of cilium assembly,1月13日,70/18112,0.049110095,0.102472146,0.055946793,Cyld,1
BP,GO:0046637,regulation of alpha-beta T cell differentiation,1月13日,71/18112,0.04979525,0.103453925,0.056482815,RT1-Db1,1
CC,GO:0042613,MHC class II protein complex,2月13日,13/18418,3.57E-05,0.002428646,0.001917352,RT1-Db1/RT1-Bb,2
CC,GO:0042611,MHC protein complex,2月13日,20/18418,8.68E-05,0.002949732,0.002328735,RT1-Db1/RT1-Bb,2
CC,GO:0097542,ciliary tip,1月13日,12/18418,0.008439682,0.16727807,0.132061634,Cyld,1
CC,GO:0000930,gamma-tubulin complex,1月13日,14/18418,0.009839886,0.16727807,0.132061634,Tubgcp4,1
CC,GO:0005770,late endosome,2月13日,260/18418,0.013974509,0.174788023,0.137990545,RT1-Db1/RT1-Bb,2
CC,GO:0005697,telomerase holoenzyme complex,1月13日,22/18418,0.015422473,0.174788023,0.137990545,Smg5,1
CC,GO:0016592,mediator complex,1月13日,39/18418,0.027189131,0.181683108,0.143434032,Cdk19,1
CC,GO:0005819,spindle,2月13日,375/18418,0.027806203,0.181683108,0.143434032,Cyld/Tubgcp4,2
CC,GO:0001772,immunological synapse,1月13日,44/18418,0.030625128,0.181683108,0.143434032,RT1-Db1,1
CC,GO:0005874,microtubule,2月13日,397/18418,0.030898349,0.181683108,0.143434032,Cyld/Tubgcp4,2
CC,GO:0008328,ionotropic glutamate receptor complex,1月13日,45/18418,0.031310981,0.181683108,0.143434032,Grin2d,1
CC,GO:0098878,neurotransmitter receptor complex,1月13日,47/18418,0.032681345,0.181683108,0.143434032,Grin2d,1
CC,GO:0098686,hippocampal mossy fiber to CA3 synapse,1月13日,50/18418,0.034733535,0.181683108,0.143434032,Grin2d,1
CC,GO:0009897,external side of plasma membrane,2月13日,461/18418,0.040634177,0.185147605,0.146169162,RT1-Db1/RT1-Bb,2
CC,GO:0005771,multivesicular body,1月13日,59/18418,0.040866018,0.185147605,0.146169162,RT1-Bb,1
CC,GO:0022627,cytosolic small ribosomal subunit,1月13日,63/18418,0.043580005,0.185147605,0.146169162,Cyld,1
CC,GO:0032153,cell division site,1月13日,67/18418,0.046286901,0.185147605,0.146169162,Tubgcp4,1
MF,GO:0023026,MHC class II protein complex binding,2月13日,14/16650,5.09E-05,0.004788455,0.00252024,RT1-Db1/RT1-Bb,2
MF,GO:0023023,MHC protein complex binding,2月13日,22/16650,0.000128857,0.006056274,0.003187512,RT1-Db1/RT1-Bb,2
MF,GO:0042605,peptide antigen binding,2月13日,35/16650,0.000330009,0.010340282,0.005442254,RT1-Db1/RT1-Bb,2
MF,GO:0003823,antigen binding,2月13日,66/16650,0.001173566,0.027578789,0.014515152,RT1-Db1/RT1-Bb,2
MF,GO:0016853,isomerase activity,2月13日,157/16650,0.006436981,0.064412548,0.033901341,Fkbp11/Mcee,2
MF,GO:0061578,Lys63-specific deubiquitinase activity,1月13日,10/16650,0.007782528,0.064412548,0.033901341,Cyld,1
MF,GO:0008353,RNA polymerase II CTD heptapeptide repeat kinase activity,1月13日,11/16650,0.008557698,0.064412548,0.033901341,Cdk19,1
MF,GO:0042608,T cell receptor binding,1月13日,11/16650,0.008557698,0.064412548,0.033901341,RT1-Db1,1
MF,GO:1990405,protein antigen binding,1月13日,12/16650,0.009332309,0.064412548,0.033901341,RT1-Bb,1
MF,GO:0051011,microtubule minus-end binding,1月13日,13/16650,0.010106361,0.064412548,0.033901341,Tubgcp4,1
MF,GO:0016595,glutamate binding,1月13日,14/16650,0.010879855,0.064412548,0.033901341,Grin2d,1
MF,GO:0044548,S100 protein binding,1月13日,14/16650,0.010879855,0.064412548,0.033901341,S100b,1
MF,GO:0015643,toxic substance binding,1月13日,15/16650,0.011652791,0.064412548,0.033901341,RT1-Bb,1
MF,GO:0016854,racemase and epimerase activity,1月13日,15/16650,0.011652791,0.064412548,0.033901341,Mcee,1
MF,GO:0004303,estradiol 17-beta-dehydrogenase activity,1月13日,16/16650,0.012425169,0.064412548,0.033901341,Akr1b8,1
MF,GO:0070034,telomerase RNA binding,1月13日,17/16650,0.01319699,0.064412548,0.033901341,Smg5,1
MF,GO:1990380,Lys48-specific deubiquitinase activity,1月13日,17/16650,0.01319699,0.064412548,0.033901341,Cyld,1
MF,GO:0004970,ionotropic glutamate receptor activity,1月13日,18/16650,0.013968255,0.064412548,0.033901341,Grin2d,1
MF,GO:0004032,alditol:NADP+ 1-oxidoreductase activity,1月13日,19/16650,0.014738963,0.064412548,0.033901341,Akr1b8,1
MF,GO:0070064,proline-rich region binding,1月13日,20/16650,0.015509114,0.064412548,0.033901341,Cyld,1
MF,GO:0004693,cyclin-dependent protein serine/threonine kinase activity,1月13日,22/16650,0.017047751,0.064412548,0.033901341,Cdk19,1
MF,GO:0042165,neurotransmitter binding,1月13日,22/16650,0.017047751,0.064412548,0.033901341,Grin2d,1
MF,GO:0097472,cyclin-dependent protein kinase activity,1月13日,22/16650,0.017047751,0.064412548,0.033901341,Cdk19,1
MF,GO:0047834,D-threo-aldose 1-dehydrogenase activity,1月13日,23/16650,0.017816237,0.064412548,0.033901341,Akr1b8,1
MF,GO:0048156,tau protein binding,1月13日,23/16650,0.017816237,0.064412548,0.033901341,S100b,1
MF,GO:0070530,K63-linked polyubiquitin modification-dependent protein binding,1月13日,23/16650,0.017816237,0.064412548,0.033901341,Sprtn,1
MF,GO:0030247,polysaccharide binding,1月13日,24/16650,0.018584168,0.064700435,0.034052861,RT1-Db1,1
MF,GO:0099604,ligand-gated calcium channel activity,1月13日,25/16650,0.019351544,0.064965899,0.034192578,Grin2d,1
MF,GO:0008066,glutamate receptor activity,1月13日,26/16650,0.020118367,0.065211259,0.034321715,Grin2d,1
MF,GO:0008106,alcohol dehydrogenase (NADP+) activity,1月13日,29/16650,0.022415516,0.068497418,0.036051273,Akr1b8,1
MF,GO:0031625,ubiquitin protein ligase binding,2月13日,304/16650,0.022694483,0.068497418,0.036051273,RT1-Bb/Smg5,2
MF,GO:0033764,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor",1月13日,32/16650,0.024707693,0.068497418,0.036051273,Akr1b8,1
MF,GO:0042277,peptide binding,2月13日,319/16650,0.024829178,0.068497418,0.036051273,RT1-Db1/RT1-Bb,2
MF,GO:0044389,ubiquitin-like protein ligase binding,2月13日,322/16650,0.025265832,0.068497418,0.036051273,RT1-Bb/Smg5,2
MF,GO:0003755,peptidyl-prolyl cis-trans isomerase activity,1月13日,34/16650,0.026233054,0.068497418,0.036051273,Fkbp11,1
MF,GO:0004033,aldo-keto reductase (NADP) activity,1月13日,34/16650,0.026233054,0.068497418,0.036051273,Akr1b8,1
MF,GO:0043015,gamma-tubulin binding,1月13日,35/16650,0.026994908,0.068581658,0.036095609,Tubgcp4,1
MF,GO:0042162,telomeric DNA binding,1月13日,36/16650,0.027756212,0.068660103,0.036136896,Smg5,1
MF,GO:0016859,cis-trans isomerase activity,1月13日,38/16650,0.029277171,0.070565488,0.037139731,Fkbp11,1
MF,GO:0016229,steroid dehydrogenase activity,1月13日,41/16650,0.031554491,0.07408232,0.038990695,Akr1b8,1
MF,GO:0051721,protein phosphatase 2A binding,1月13日,42/16650,0.032312501,0.07408232,0.038990695,Smg5,1
MF,GO:0033218,amide binding,2月13日,398/16650,0.037356662,0.083607768,0.044004088,RT1-Db1/RT1-Bb,2
MF,GO:1904315,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,1月13日,52/16650,0.03986254,0.087141367,0.045863877,Grin2d,1
MF,GO:0031593,polyubiquitin modification-dependent protein binding,1月13日,55/16650,0.042116926,0.087234268,0.045912772,Sprtn,1
MF,GO:0099529,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,1月13日,55/16650,0.042116926,0.087234268,0.045912772,Grin2d,1
MF,GO:0022824,transmitter-gated ion channel activity,1月13日,57/16650,0.043617134,0.087234268,0.045912772,Grin2d,1
MF,GO:0022835,transmitter-gated channel activity,1月13日,57/16650,0.043617134,0.087234268,0.045912772,Grin2d,1